SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Murray CJL, Lopez AD. Evidence-based health policy—lessons from the global burden of disease study. Science 1996; 274: 7403.
  • 2
    Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Cambridge, MA, 1996.
  • 3
    Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997; 349: 143642.
  • 4
    Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmacoeconomics 2001; 19: 24554.
  • 5
    Barnes PJ. Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol. Sci. 1998; 19: 41523.
  • 6
    American Lung Association. American Lung Association Fact Sheet: Chronic Obstructive Pulmonary Disease (COPD). January 2001. Available from URL: http://www.lungusa.org
  • 7
    Saenghirunvattana S, Kongngeon V, Aeimrerksiri B et al. Chronic obstructive pulmonary diseases in Thailand: incidence, prevalence, present status and future trends. J. Med. Assoc. Thai. 2001; 84: 140711.
  • 8
    Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8: 1721.
  • 9
    Schau BS, Lopez-Vidriero M, Peabody J et al. Chronic obstructive pulmonary disease: a prevalence estimation model. Am. J. Respir. Crit. Care Med. 2000; 16: A799.
  • 10
    Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003; 8: 1928.
  • 11
    Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. National Institutes of Health. National Heart, Lung and Blood Institute, publication No. 95–3659, January 1995, reprinted May 1996.
  • 12
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. NIH, National Heart, Lung, and Blood Institute, publication No. 2701, April 2001.
  • 13
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. Executive Summary. NIH, National Heart, Lung, and Blood Institute, publication No. 2701A, March 2001.
  • 14
    Fabbri LM, Hurd SS for the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD update. Eur. Respir. J. 2003; 22: 12.
  • 15
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. NIH, National Heart, Lung, and Blood Institute, publication updated 2003.
  • 16
    O'Donnell DE, Hernandez P, Aaron S et al. Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. Can. Respir. J. 2003; 10: 1835.
  • 17
    Brocklebank D, Ram F, Wright J et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol. Assess. 2001; 5 (26): 1149.
  • 18
    Lam WK, Zhong NS, Tan WC. Overview on SARS in Asia and the world. Respirology 2003; 8 (Suppl.): S25.
  • 19
    Fleck F. WHO says SARS outbreak is over, but fight should go on. BMJ 2003; 327: 70.
  • 20
    Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology 2003; 8 (Suppl.): S914.
  • 21
    Ho PL, Tang XP, Seto WH. SARS: hospital infection control and admission strategies. Respirology 2003; 8 (Suppl.): S415.
  • 22
    Soto FJ, Varkey B. Evidence-based to acute exacerbations of COPD. Curr. Opin. Pulm. Med. 2003; 9: 11724.
  • 23
    World Health Organisation, 2 September, 2003. Influenza Vaccination for the 2003–2004 Season: Recommendations in the Context of Concern about SARS. http://www.who.International/csr/disease/influenza/sars. Accessed: 15 September, 2003.
  • 24
    World  Health Organisation, 3 July, 2003. Update 94: Preparing for the Next Influenza Season in  a  World  Altered  by  SARS . http://www.who.International/csr/disease/influenza/sars. Accessed: 15 September 2003.
  • 25
    Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 201120.
  • 26
    Brooks D, Lacasse Y, Goldstein RS. Pulmonary rehabilitation programs in Canada: national survey. Can. Respir. J. 1999; 6: 5563.
  • 27
    Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 2003; 124: 947.